Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04828603 · ClinicalTrials.gov registry record
Understanding Allergies and Sensitizations in Healthy and Allergic Individuals
A clinical trial of Allergy, sponsored by Stanford University.
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 1
- Study location
NCT04828603: Recruiting study of Allergy, sponsored by Stanford University.
NCT04828603 is a study of Allergy that is actively recruiting participants, run by Stanford University. The registered enrollment target is 2,500 participants, above the 166-participant average among 15 other Allergy trials with a reported enrollment target (1406% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04828603, a study of Allergy, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to strengthen our ability to accurately diagnose allergies and understand cellular, humoral, genetic components and physiological changes in allergic disease
Primary Outcome
Standardized skin testing performed to detect sensitivity to allergens of interest
Conditions Studied
Study Locations (1)
California
- Sean N. Parker Center for Allergy and Asthma Research, Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2007-10 |
| Est. Completion | 2028-12 |
What NCT04828603 shows while recruiting
NCT04828603 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 166-participant average among 15 other Allergy trials with a reported enrollment target (1406% higher).
The record links to 1 condition, with Allergy appearing as the primary indexed condition, and to 0 interventions.
NCT04828603 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04828603 about?
NCT04828603 is a clinical study titled "Understanding Allergies and Sensitizations in Healthy and Allergic Individuals". The purpose of this study is to strengthen our ability to accurately diagnose allergies and understand cellular, humoral, genetic components and physiological changes in allergic disease
What is the current status of trial NCT04828603?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2007-10. Estimated completion is 2028-12.
What conditions does trial NCT04828603 study?
This clinical trial studies the following conditions: Allergy.
Who is sponsoring clinical trial NCT04828603?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04828603 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Allergy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04828603's enrollment target sits among peer trials
2,500 1st of 15 higher than 15 of 15 other Allergy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Allergy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron
RECRUITING · Phase 4
-
Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
RECRUITING · Phase 3
-
Childhood Allergy and the Neonatal Environment
ACTIVE NOT RECRUITING
-
Urban Environmental Factors and Childhood Asthma
COMPLETED
-
Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
COMPLETED · Phase 2
-
Vitamin D, Steroids, and Asthma in African American Youth
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia